期刊文献+

CYP17基因多态性与乙型肝炎病毒感染后肝硬化、肝细胞癌的关系 被引量:3

Genetic polymorphisms of CYP17 and risks of cirrhosis or hepatocellular carcinoma in hepatitis B-infected patients
下载PDF
导出
摘要 目的研究参与雌激素代谢的细胞色素P45017(Cytochrome P45017,CYP17)MspA1I位点基因多态性与山东地区汉族人乙型肝炎病毒(hepatitis B virus,HBV)感染后肝硬化、肝细胞癌(HCC)的关系。方法应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术,对山东地区96例乙肝相关性HCC患者、107例乙肝后肝硬化患者、82例慢性乙型肝炎患者、91例乙型肝炎表面抗原(HBsAg)携带者、80例健康对照组的CYP17基因MspA1I位点的T/C多态进行研究。结果与携带者相比,CYP17 A2/A2基因型明显增加了女性HBV感染患者HCC的发病风险(OR=5.93,P=0.002),尤其在绝经后的妇女,OR增加至6.18,P=0.003,而在男性患者中差异无统计学意义。乙肝肝硬化患者与携带者相比,A2/A2基因型频率差异亦无统计学意义(P>0.05)。结论CYP17 MspA1I多态位点A2/A2基因型与山东地区女性HBV感染后HCC的易感性有关。 Objective To explore the relationship between genetic polymorphisms of CYP17 MspA1I and cirrhosis or hepatocellular carcinoma in hepatitis B infected patients of Shandong Pmvince. Methods 80 healthy controls and 376 HBV patients including 96 hepatocelluar carcinomas(HCC), 107 cirrhosis, 82 hepatitis and 91 HBsAg carriers were determined the T→C in CYP17 MspA1I by palymerase chain reaction and restriction fragment length palymorphism (PCR-RFLP). Results Compared with the carriers, the ( - 34) A2/A2 genotype of CYP17 significantly increased the risks of HCC patients. Females mostly contributed to this association ( OR = 5.93, P = 0.002), and the OR values increased in post-menopausal women ( OR = 6.18, P = 0.003) but not in male subjects. There were no significant differences in the distribution of CYP 17 genotypes between carriers and cirrhosis ( P 〉 0.05). Conclusion CYP17 MspA1I genotypes A2/A2 may be related to liver cancer risk in HBV-infected women in Shandong Province.
出处 《山东大学学报(医学版)》 CAS 北大核心 2008年第1期76-79,共4页 Journal of Shandong University:Health Sciences
关键词 肝炎病毒 乙型 肝细胞 肝硬化 多态性 CYP17 Hepatitis B virus Carcinoma, hepatocellular Cirrhosis Polymorphism CYP17
  • 相关文献

参考文献10

  • 1Poynard T, Ratziu Y, Charlotte F, et al. Rates and risk factors of hver fibrosis progression in patients with chronic hepatitis C [J]. J Hepatol, 2001, 34(5):730-739.
  • 2Wasmuth H E, Lammert F, Matem S. Genetic risk factors for Hepatic fibrosis in chronic liver diseases[ J ]. Med Klin( Munich), 2003, 98(12) :754-762.
  • 3Berstein L M, Imyanitov E N, Kovalevskij A J, et al. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity [ J ]. Cancer Lett, 2004, 207(2) : 191-196.
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 5Berstein L M, Imyanitov E N, Gamajunova V B, et al. CYP17 genetic polymorphism in endometrial cancer: are only steroids involved? [J]. Cancer lea, 2002, 180(1) :47-53.
  • 6李定国,刘清华.雌激素与肝纤维化研究现状[J].国外医学(消化系疾病分册),2004,24(4):195-197. 被引量:7
  • 7Yasuda M, Shimizu I, Shiba M, et al. Suppressive effects of estradiolon dimethylnitrosamine induced fibrosis of the liver in rats[J]. Hepatology, 1999, 29(3):719-727.
  • 8Tanaka K, Sakai H, Hashizume M, et al. Serum testosterone: Estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients [ J ]. Cancer Res, 2000, 60 (18) :5106-5110.
  • 9Rossi L, Leveri M, Chiara G, et al. Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C infected patients[J]. J Hepatol, 2003, 39(4) : 564-570.
  • 10Yin P H, Lee H C, Chau G Y, et al. Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females[J]. Cancer Lett, 2004, 212(2) :195-201.

共引文献14015

同被引文献26

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部